Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Abstract Coronavirus disease 2019 (COVID-19), with a high prevalence rate, has rapidly
infected millions of people around the world. Since viral infections can disrupt the …

Despite the emergence of high quality randomized trial data with the use of antithrombotic
agents to reduce the risk of thromboembolism, end‐organ failure, and possibly mortality in …

2. Methods This study followed the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) reporting guideline (Supplementary file 1). Data were obtained …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the virus responsible
for the COVID-19 pandemic. Patients may present as asymptomatic or demonstrate mild to …

Background: COVID-19 (coronavirus disease 2019) is associated with heightened risks of
venous and arterial thrombosis and hospitalization due to respiratory failure. To assess …

Background Patients with severe COVID-19 seem to evolve with a compromised antiviral
response and hyperinflammation. Neutrophils are critical players in COVID-19. IL-17A plays …

Pulmonary thromboembolic events have been linked to coronavirus disease 2019 (COVID‐
19), but their incidence and long‐term sequelae remain unclear. We performed a systematic …

BACKGROUND Evidence regarding the safety and efficacy of anticoagulant
thromboprophylaxis among pediatric patients hospitalized for coronavirus disease 2019 …